UNSPSC 51282909: Ciprofloxacin

This classification denotes a quinolone antibiotic and antitubercular agent with the molecular formula C17H18FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5E8K9I0O4U, chemically known as 86393-32-0 (hydrochloride, monohydrate) but generally known as ciprofloxacin, which bears US NIH Compound Identifier 2764. European Medicines Agency schedules Ciprofloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07470MIG.

UNSPSC 51282909 Ciprofloxacin is a Commodity code that nominally designates a specific antibiotic pharmaceutical product, but recent state and local procurement activity under this code shows little alignment with the code's narrow product scope. The recent opportunities posted against this code span emergency response supplies, pharmacy benefit program design, generic multi-source pharmaceuticals, and direct-to-manufacturer prescription initiatives — none of which target ciprofloxacin procurement specifically. The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The work actually being solicited covers naloxone and drug deactivation systems for community health, exploration of direct pharmacy contracting models outside traditional pharmacy benefit manager and group purchasing organization relationships, medical and first aid supplies for emergency response, and framework agreements for generic pharmaceuticals and over-the-counter products distributed through authorized wholesalers.

Recent activity concentrates in the Southeast (Florida) and Midwest (Minnesota, with multi-state extension to Oregon), with secondary activity in Texas and Florida. Representative recent opportunities include the Seminole County IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a two-year initial term and one-year renewal option; the City of Tampa IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000.00 and designated as a Small Local Business Enterprise sheltered market with a 5 percent bid discount capped at $10,000; and the MMCAP RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and over-the-counter products across state and local facilities. The code shows significant category misalignment — procurement offices appear to be tagging diverse pharmaceutical and medical supply solicitations under a ciprofloxacin commodity code rather than isolating ciprofloxacin-specific demand.